Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2022-005200
Abstract: Background Specific immune response is a hallmark of cancer immunotherapy and shared tumor-associated antigens (TAAs) are important targets. Recent advances using combined cellular therapy against multiple TAAs renewed the interest in this class of antigens.… read more here.
Keywords: activated cells; cell; esophago gastric; taas ... See more keywords